Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
carboxymethylcellulose + glycerin + N-acetylcarnosine
- Development stage
- Unknown
- Lead developer
- Innovative Vision Products
- Modality
- Small Molecules, Peptides, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Ophthalmic
01
Overview
Sionac is an ophthalmic lubricant and antioxidant combination eye drop formulated to relieve dry eyes, ocular irritation, and protect eye tissues from oxidative stress. It contains carboxymethylcellulose sodium (0.3% w/v), glycerin (1% w/v), and N-acetylcarnosine (1% w/v). Carboxymethylcellulose sodium and glycerin act as artificial tears and humectants, providing immediate lubrication, stabilizing the tear film, and protecting the corneal epithelium from hyperosmolar injury. N-acetylcarnosine is a dipeptide antioxidant that penetrates the cornea to neutralize free radicals, helping to protect ocular tissues from oxidative damage and potentially slowing the progression of age-related cataracts. Sionac is marketed by Soviet Pharmaceuticals for the management of dry eye syndrome and overall ocular surface health.
- Brand names
- Sionac
- Other names
- carboxymethylcellulose + glycerin + n-acetylcarnosinecarboxymethylcellulose sodium + glycerin + N-acetylcarnosinesodium carboxymethylcellulose + glycerin + N-acetylcarnosine
02
Targets
Transition metal ions / redox-active metalsCRY (Crystallin family)
Beyond the preview
Go deeper on carboxymethylcellulose + glycerin + N-acetylcarnosine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on carboxymethylcellulose + glycerin + N-acetylcarnosine.